WTAP/m6A/YTHDF1-mediated upregulation of Midkine expression drives clear cell renal cell carcinoma metastasis: insights from single-cell sequencing

Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer. It is highly heterogeneous and exhibits a pronounced tendency towards haematogenous metastasis, which together contribute to poor overall survival. The molecular and cellular programs that distinguish metastatic from non-metastatic primary ccRCC remain incompletely defined. Here, through single-cell RNA sequencing of primary tumours from non-metastatic and metastatic ccRCC patients, we revealed marked differences in the tumour microenvironment and identified Midkine ( MDK ) as a molecular signature associated with ccRCC progression and poor prognosis. MDK was significantly upregulated in metastatic ccRCC, particularly in PT and dPT1 tumour cell lineages, and mediated crosstalk between tumour cells and M2-like macrophage subtypes. These macrophages in turn interacted with CD8 + T cells through SPP1 and CD24, suggesting a potential immunosuppressive mechanism. The genes upregulated in CD8 + T cells from metastatic ccRCC patients were enriched in chemokine receptor–chemokine interactions and IL-10 signalling. Mechanistically, WTAP promoted m6A methylation of MDK mRNA and increased its stability by facilitating YTHDF1 binding, thus increasing MDK protein levels and driving ccRCC cell proliferation, invasion, metastasis, and epithelial–mesenchymal transition while inhibiting apoptosis. These findings define an MDK -centred immunosuppressive axis and a WTAP/m6A/YTHDF1/MDK regulatory pathway that promotes ccRCC malignant progression, highlighting MDK as a potential prognostic biomarker and therapeutic target for metastatic ccRCC.

Authors

Institutions

Publication Details

Journal
Molecular Biomedicine
Published
2026-11-22
DOI
https://doi.org/10.1186/s43556-026-00665-4
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

WTAP/m6A/YTHDF1-mediated upregulation of Midkine expression drives clear cell renal cell carcinoma metastasis: insights from single-cell sequencing

Ying Wang, Zhaofeng Li, Ke Wang, Xinbao Yin et al.
Molecular Biomedicine
RNA modifications and cancer
article

WTAP/m6A/YTHDF1-mediated upregulation of Midkine expression drives clear cell renal cell carcinoma metastasis: insights from single-cell sequencing

Ying Wang, Zhaofeng Li, Ke Wang, Xinbao Yin, Zongliang Zhang, Xueping Zheng, Xunhua Li, Han Yang, Kai Zhao, Guanqun Zhu
article en

Abstract

Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer. It is highly heterogeneous and exhibits a pronounced tendency towards haematogenous metastasis, which together contribute to poor overall survival. The molecular and cellular programs that distinguish metastatic from non-metastatic primary ccRCC remain incompletely defined. Here, through single-cell RNA sequencing of primary tumours from non-metastatic and metastatic ccRCC patients, we revealed marked differences in the tumour microenvironment and identified Midkine ( MDK ) as a molecular signature associated with ccRCC progression and poor prognosis. MDK was significantly upregulated in metastatic ccRCC, particularly in PT and dPT1 tumour cell lineages, and mediated crosstalk between tumour cells and M2-like macrophage subtypes. These macrophages in turn interacted with CD8 + T cells through SPP1 and CD24, suggesting a potential immunosuppressive mechanism. The genes upregulated in CD8 + T cells from metastatic ccRCC patients were enriched in chemokine receptor–chemokine interactions and IL-10 signalling. Mechanistically, WTAP promoted m6A methylation of MDK mRNA and increased its stability by facilitating YTHDF1 binding, thus increasing MDK protein levels and driving ccRCC cell proliferation, invasion, metastasis, and epithelial–mesenchymal transition while inhibiting apoptosis. These findings define an MDK -centred immunosuppressive axis and a WTAP/m6A/YTHDF1/MDK regulatory pathway that promotes ccRCC malignant progression, highlighting MDK as a potential prognostic biomarker and therapeutic target for metastatic ccRCC.

Molecular BiomedicineVol. 7(1)
Army Medical University (CN), Harbin Medical University (CN), Chinese Center For Disease Control and Prevention (CN), Nantong University (CN), Affiliated Hospital of Qingdao University (CN), Southwest Hospital (CN)
RNA modifications and cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon